Form 4: NeuroPace Director Lisa Andrade Acquires Stock Options
SEC Form 4 Filing
Director Lisa Andrade acquired stock options in NeuroPace Inc. on June 7, 2024, according to a Form 4 filing.
Summary
- Lisa Andrade, a director of NeuroPace Inc., filed a Form 4 disclosing a transaction on June 7, 2024.
- Andrade acquired 17,774 stock options with an exercise price of $6.47.
- The options vest in twelve equal monthly installments.
- The options expire on June 6, 2034.
- Leah Akin, Attorney-in-Fact, signed the form on June 11, 2024.
- A Power of Attorney document was included, granting certain individuals the authority to execute forms on behalf of Lisa Andrade.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing related to stock option grants.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2024-03-13 | Date of Power of Attorney execution. |
| 2024-06-07 | Date of stock option acquisition. |
| 2024-06-11 | Date of Form 4 filing. |
| 2034-06-06 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.